Increased Susceptibility of IgA-Deficient Mice to Pulmonary Francisella tularensis Live Vaccine Strain Infection

被引:18
|
作者
Furuya, Yoichi [1 ]
Kirimanjeswara, Girish S. [1 ]
Roberts, Sean [1 ]
Metzger, Dennis W. [1 ]
机构
[1] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA
基金
美国国家卫生研究院;
关键词
IMMUNOGLOBULIN-A; RESPIRATORY-INFECTION; INTRANASAL INFECTION; PROTECTIVE IMMUNITY; GAMMA-INTERFERON; INFLUENZA-VIRUS; T-CELLS; ANTIBODIES; TULAREMIA; CHALLENGE;
D O I
10.1128/IAI.00408-13
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Francisella tularensis, the causative agent of tularemia, is most deadly in the pneumonic form; therefore, mucosal immunity is an important first line of defense against this pathogen. We have now evaluated the lethality of primary F. tularensis live vaccine strain (LVS) pulmonary infection in mice that are defective in IgA (IgA(-/-) mice), the predominant mucosal Ig isotype. The results showed that IgA(-/-) mice were more susceptible than IgA(+/+) mice to intranasal F. tularensis LVS infection, despite developing higher levels of LVS-specific total, IgG, and IgM antibodies in the bronchoalveolar lavage specimens following infection. In addition, the absence of IgA resulted in a significant increase in bacterial loads and reduced survival. Interestingly, IgA(-/-) mice had lower pulmonary gamma interferon (IFN-gamma) levels and decreased numbers of IFN-gamma-secreting CD4(+) and CD8(+) T cells in the lung on day 9 postinfection compared to IgA(+/+) mice. Furthermore, IgA(-/-) mice displayed reduced interleukin 12 (IL-12) levels at early time points, and supplementing IgA(-/-) mice with IL-12 prior to LVS challenge induced IFN-gamma production by NK cells and rescued them from mortality. Thus, IgA(-/-) mice are highly susceptible to primary pulmonary LVS infections not only because of IgA deficiency but also because of reduced IFN-gamma responses.
引用
下载
收藏
页码:3434 / 3441
页数:8
相关论文
共 50 条
  • [1] LIVE VACCINE STRAIN OF FRANCISELLA-TULARENSIS - INFECTION AND IMMUNITY IN MICE
    FORTIER, AH
    SLAYTER, MV
    ZIEMBA, R
    MELTZER, MS
    NACY, CA
    INFECTION AND IMMUNITY, 1991, 59 (09) : 2922 - 2928
  • [2] Differing Effects of Interleukin-10 on Cutaneous and Pulmonary Francisella tularensis Live Vaccine Strain Infection
    Metzger, Dennis W.
    Salmon, Sharon L.
    Kirimanjeswara, Girish
    INFECTION AND IMMUNITY, 2013, 81 (06) : 2022 - 2027
  • [3] Formulation and Stabilization of Francisella tularensis Live Vaccine Strain
    Ohtake, Satoshi
    Martin, Russell A.
    Saxena, Atul
    Lechuga-Ballesteros, David
    Santiago, Araceli E.
    Barry, Eileen M.
    Vu Truong-Le
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) : 3076 - 3087
  • [4] Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections
    Mares, C. A.
    Ojeda, S. S.
    Li, Q.
    Morris, E. G.
    Coalson, J. J.
    Teale, J. M.
    EXPERIMENTAL GERONTOLOGY, 2010, 45 (02) : 91 - 96
  • [5] Reproducible and Quantitative Model of Infection of Dermacentor variabilis with the Live Vaccine Strain of Francisella tularensis
    Coburn, Jenifer
    Maier, Tamara
    Casey, Monika
    Padmore, Lavinia
    Sato, Hiromi
    Frank, Dara W.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2015, 81 (01) : 386 - 395
  • [6] Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain
    Aperis, George
    Fuchs, Beth Burgwyn
    Anderson, Christine A.
    Warner, John E.
    Calderwood, Stephen B.
    Mylonakis, Eleftherios
    MICROBES AND INFECTION, 2007, 9 (06) : 729 - 734
  • [7] Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity
    Bosio, CM
    Elkins, KL
    INFECTION AND IMMUNITY, 2001, 69 (01) : 194 - 203
  • [8] Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain
    Havlasová, J
    Hernychová, L
    Halada, P
    Pellantová, W
    Krejsek, J
    Stulík, J
    Macela, A
    Jungblut, PR
    Larsson, P
    Forsman, M
    PROTEOMICS, 2002, 2 (07) : 857 - 867
  • [9] Interaction of Francisella tularensis live vaccine strain with eukaryotic cells
    Krocova, Z
    Stulik, J
    Andelova, H
    Hartmanova, B
    Hernychova, L
    Hubalek, M
    Lenco, J
    Brychta, M
    Holicka, M
    Loudova, M
    Novosad, J
    Kroca, M
    Macela, A
    IMMUNOLOGY 2004: IMMUNODEFICIENCY, INFECTIOUS DISEASES, IMMUNOMODULATION, AND VACCINES, 2004, : 417 - 421
  • [10] PASSIVE PROTECTION OF MICE AGAINST LETHAL FRANCISELLA-TULARENSIS (LIVE TULAREMIA VACCINE STRAIN) INFECTION BY THE SERA OF HUMAN RECIPIENTS OF THE LIVE TULAREMIA VACCINE
    DRABICK, JJ
    NARAYANAN, RB
    WILLIAMS, JC
    LEDUC, JW
    NACY, CA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1994, 308 (02): : 83 - 87